Its symptoms typically start in early childhood but sometimes aren't diagnosed until later in childhood, or until adulthood - if at all.Along with inattentiveness and hyperactivity, symptoms of the ...

Big news is giving this biotech a huge lift on Thursday. The post Mesoblast share price rockets 30% on big US FDA news ...

RYONCIL is the first FDA-approved therapy for children aged 2 months and older, including adolescents ... including REVASCOR ® for cardiovascular diseases and rexlemestrocel-L for inflammatory pain ...